Mania and hypomania are disorders where chemical imbalances in the brain cause an abnormally and persistently elevated mood. While this may sound useful or even enjoyable, in reality, these conditions ...
Olanzapine was better than placebo, but its rate of response was poor in this industry-sponsored study. Adolescent mania is associated with poor prognosis (Journal Watch Psychiatry May 7 2007), and ...
There are numerous prescribed drugs and non-prescription substances that can activate the onset of mood elevation symptoms quite like what is observed with episodes of bipolar hypomania or mania. For ...
WILMINGTON, Del., Oct. 10 /PRNewswire-FirstCall/ -- AstraZeneca (NYSE: AZN - News) today announced that the U.S. Food and Drug Administration (FDA) has approved once ...
Investor's Business Daily on MSN
Biohaven Slumps, Again, As Bipolar Setback Outweighs A $4 Billion Opportunity
Biohaven stock tumbled for the second day running Tuesday after its bipolar mania treatment failed in a three-week study. Analysts called the stock reaction overdone, while Chief Executive Vlad Coric ...
WHEN the prevalence of a medical condition leaps fivefold in eight years and it is not an infectious disease, something strange is going on. That is what has happened to childhood bipolar disorder in ...
Each month, The Clinical Advisor makes one new clinical feature available ahead of print. Don’t forget to take the poll. The results will be published in the next month’s issue. Bipolar disorder is a ...
There are numerous prescribed drugs and non-prescription substances that can activate the onset of mood elevation symptoms quite like what is observed with episodes of bipolar hypomania or mania. For ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback